Veterinary Medicines

DOLISOVET INTRAMAMMAIRE

Authorised
  • ATROPA BELLA-DONNA D1
  • Solanum dulcamara C1
  • ECHINACEA D1
  • CALENDULA MOTHER TINCTURE
Download as PDF

Product identification

Medicine name:
DOLISOVET INTRAMAMMAIRE
Active substance:
  • ATROPA BELLA-DONNA D1
  • Solanum dulcamara C1
  • ECHINACEA D1
  • CALENDULA MOTHER TINCTURE
Target species:
  • Cattle (cow)
  • Sheep (ewe)
  • Goat (adult female)
Route of administration:
  • Intramammary use

Product details

Active substance and strength:
  • ATROPA BELLA-DONNA D1
    0.08
    gram(s)
    /
    1.00
    Syringe
  • Solanum dulcamara C1
    0.05
    gram(s)
    /
    1.00
    Syringe
  • ECHINACEA D1
    0.08
    gram(s)
    /
    1.00
    Syringe
  • CALENDULA MOTHER TINCTURE
    0.05
    gram(s)
    /
    1.00
    Syringe
Pharmaceutical form:
  • Intramammary ointment
Withdrawal period by route of administration:
  • Intramammary use
    • Cattle (cow)
      • Meat and offal
        0
        day
    • Sheep (ewe)
      • Meat and offal
        0
        day
    • Goat (adult female)
      • Meat and offal
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QV03AX
Legal status of supply:
  • Veterinary medicinal product not subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • France
Available in:
  • France
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Legal basis not covered by Directive 2001/82/EC
Marketing authorisation holder:
  • Boiron
Marketing authorisation date:
Manufacturing sites for batch release:
  • Boiron
Responsible authority:
  • French Agency For Food, Environmental And Occupational Health & Safety
Authorisation number:
  • FR/V/7148822 6/2006
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
French (PDF)
Published on: 4/04/2022
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."